03:03 PM EDT, 08/19/2025 (MT Newswires) -- Rein Therapeutics ( RNTX ) shares fell 6.2% in recent Tuesday trading after Brookline Capital downgraded the stock to hold from buy.
Trading volume stood at over 54,901 shares, versus the daily average of 42,806.
Price: 1.06, Change: -0.07, Percent Change: -6.19